Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 6085 to 6093 of 6093 entries
Sorted by: Best Match Show Resources per page
Colon angiolipoma with intussusception resected by laparoscopy-assisted surgery: a case report.

Journal of surgical case reports

Kimura A, Morinaga N, Tajima K, Ogata K, Kato H, Sohda M, Shirabe K, Saeki H.
PMID: 34386190
J Surg Case Rep. 2021 Aug 10;2021(8):rjab329. doi: 10.1093/jscr/rjab329. eCollection 2021 Aug.

Angiolipomas are benign mesenchymal tumors that often occur under the skin of the upper extremity or thoracic and abdominal walls. Angiolipomas of the digestive tract are rare. Here, we describe a case of transverse colon angiolipoma with intussusception resected...

Cite
Kimura A, Morinaga N, Tajima K, et al. Colon angiolipoma with intussusception resected by laparoscopy-assisted surgery: a case report. J Surg Case Rep. 2021;2021(8):rjab329doi: 10.1093/jscr/rjab329.
Kimura, A., Morinaga, N., Tajima, K., Ogata, K., Kato, H., Sohda, M., Shirabe, K., & Saeki, H. (2021). Colon angiolipoma with intussusception resected by laparoscopy-assisted surgery: a case report. Journal of surgical case reports, 2021(8), rjab329. https://doi.org/10.1093/jscr/rjab329
Kimura, Akiharu, et al. "Colon angiolipoma with intussusception resected by laparoscopy-assisted surgery: a case report." Journal of surgical case reports vol. 2021,8 (2021): rjab329. doi: https://doi.org/10.1093/jscr/rjab329
Kimura A, Morinaga N, Tajima K, Ogata K, Kato H, Sohda M, Shirabe K, Saeki H. Colon angiolipoma with intussusception resected by laparoscopy-assisted surgery: a case report. J Surg Case Rep. 2021 Aug 10;2021(8):rjab329. doi: 10.1093/jscr/rjab329. eCollection 2021 Aug. PMID: 34386190; PMCID: PMC8354678.
Copy Download .nbib Format: NLM
Japanese Project for Telepsychiatry Evaluation during COVID-19: Treatment Comparison Trial (J-PROTECT): Rationale, design, and methodology.

Contemporary clinical trials

Kishimoto T, Kinoshita S, Bun S, Sato Y, Kitazawa M, Kikuchi T, Sado M, Takamiya A, Mimura M, Nakamae T, Abe Y, Kanazawa T, Kawabata Y, Tomita H, Abe K, Hishimoto A, Asami T, Suda A, Watanabe Y, Amagai T, Sakuma K, Kida H, Funayama M, Kimura H, Sato A, Fujiwara S, Nagao K, Sugiyama N, Takamiya M, Kodama H, Azekawa T.
PMID: 34653648
Contemp Clin Trials. 2021 Dec;111:106596. doi: 10.1016/j.cct.2021.106596. Epub 2021 Oct 13.

INTRODUCTION: The COVID-19 pandemic has had a profound impact on the mental health of people around the world. Anxiety related to infection, stress and stigma caused by the forced changes in daily life have reportedly increased the incidence and...

Cite
Kishimoto T, Kinoshita S, Bun S, et al. Japanese Project for Telepsychiatry Evaluation during COVID-19: Treatment Comparison Trial (J-PROTECT): Rationale, design, and methodology. Contemp Clin Trials. 2021;111:106596doi: 10.1016/j.cct.2021.106596.
Kishimoto, T., Kinoshita, S., Bun, S., Sato, Y., Kitazawa, M., Kikuchi, T., Sado, M., Takamiya, A., Mimura, M., Nakamae, T., Abe, Y., Kanazawa, T., Kawabata, Y., Tomita, H., Abe, K., Hishimoto, A., Asami, T., Suda, A., Watanabe, Y., Amagai, T., Sakuma, K., Kida, H., Funayama, M., Kimura, H., Sato, A., Fujiwara, S., Nagao, K., Sugiyama, N., Takamiya, M., Kodama, H., Azekawa, T. (2021). Japanese Project for Telepsychiatry Evaluation during COVID-19: Treatment Comparison Trial (J-PROTECT): Rationale, design, and methodology. Contemporary clinical trials, 111106596. https://doi.org/10.1016/j.cct.2021.106596
Kishimoto, Taishiro, et al. "Japanese Project for Telepsychiatry Evaluation during COVID-19: Treatment Comparison Trial (J-PROTECT): Rationale, design, and methodology." Contemporary clinical trials vol. 111 (2021): 106596. doi: https://doi.org/10.1016/j.cct.2021.106596
Kishimoto T, Kinoshita S, Bun S, Sato Y, Kitazawa M, Kikuchi T, Sado M, Takamiya A, Mimura M, Nakamae T, Abe Y, Kanazawa T, Kawabata Y, Tomita H, Abe K, Hishimoto A, Asami T, Suda A, Watanabe Y, Amagai T, Sakuma K, Kida H, Funayama M, Kimura H, Sato A, Fujiwara S, Nagao K, Sugiyama N, Takamiya M, Kodama H, Azekawa T. Japanese Project for Telepsychiatry Evaluation during COVID-19: Treatment Comparison Trial (J-PROTECT): Rationale, design, and methodology. Contemp Clin Trials. 2021 Dec;111:106596. doi: 10.1016/j.cct.2021.106596. Epub 2021 Oct 13. PMID: 34653648; PMCID: PMC8511868.
Copy Download .nbib Format: NLM
Infrequent use of nighttime dialysis for emergency admission due to worsening heart failure in patients on maintenance hemodialysis.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

Aizawa N, Konishi M, Kitai T, Tsujisaka Y, Kawase Y, Shimada N, Tamura K, Kimura K, Ohya Y.
PMID: 33686756
Ther Apher Dial. 2021 Mar 08; doi: 10.1111/1744-9987.13644. Epub 2021 Mar 08.

In the emergency admission due to worsening heart failure (HF) in patients on maintenance hemodialysis, emergent dialysis may be indicated, which increases personnel expenses. To clarify the characteristics and in-hospital management of the patients, we conducted a multicenter retrospective...

Cite
Aizawa N, Konishi M, Kitai T, et al. Infrequent use of nighttime dialysis for emergency admission due to worsening heart failure in patients on maintenance hemodialysis. Ther Apher Dial. 2021;doi: 10.1111/1744-9987.13644.
Aizawa, N., Konishi, M., Kitai, T., Tsujisaka, Y., Kawase, Y., Shimada, N., Tamura, K., Kimura, K., & Ohya, Y. (2021). Infrequent use of nighttime dialysis for emergency admission due to worsening heart failure in patients on maintenance hemodialysis. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, . https://doi.org/10.1111/1744-9987.13644
Aizawa, Naoki, et al. "Infrequent use of nighttime dialysis for emergency admission due to worsening heart failure in patients on maintenance hemodialysis." Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy vol. (2021). doi: https://doi.org/10.1111/1744-9987.13644
Aizawa N, Konishi M, Kitai T, Tsujisaka Y, Kawase Y, Shimada N, Tamura K, Kimura K, Ohya Y. Infrequent use of nighttime dialysis for emergency admission due to worsening heart failure in patients on maintenance hemodialysis. Ther Apher Dial. 2021 Mar 08; doi: 10.1111/1744-9987.13644. Epub 2021 Mar 08. PMID: 33686756.
Copy Download .nbib Format: NLM
Bilateral lung transplantation in a 9-year-old girl with bronchopulmonary dysplasia with pulmonary hypertension.

Pediatric pulmonology

Ota C, Saito R, Tominaga J, Iwasawa S, Hirama T, Matsuda Y, Ono K, Onoki T, Kimura M, Kawabata Y, Okada Y.
PMID: 34350735
Pediatr Pulmonol. 2021 Oct;56(10):3417-3421. doi: 10.1002/ppul.25597. Epub 2021 Aug 05.

BACKGROUND: Bronchopulmonary dysplasia (BPD) is a chronic respiratory disease that occurs in premature infants and the prognosis is variable depending on the comorbidities including fibrosis, emphysema, or pulmonary hypertension (PH). We present a case of a 9-year-old girl who...

Cite
Ota C, Saito R, Tominaga J, et al. Bilateral lung transplantation in a 9-year-old girl with bronchopulmonary dysplasia with pulmonary hypertension. Pediatr Pulmonol. 2021;56(10):3417-3421doi: 10.1002/ppul.25597.
Ota, C., Saito, R., Tominaga, J., Iwasawa, S., Hirama, T., Matsuda, Y., Ono, K., Onoki, T., Kimura, M., Kawabata, Y., & Okada, Y. (2021). Bilateral lung transplantation in a 9-year-old girl with bronchopulmonary dysplasia with pulmonary hypertension. Pediatric pulmonology, 56(10), 3417-3421. https://doi.org/10.1002/ppul.25597
Ota, Chiharu, et al. "Bilateral lung transplantation in a 9-year-old girl with bronchopulmonary dysplasia with pulmonary hypertension." Pediatric pulmonology vol. 56,10 (2021): 3417-3421. doi: https://doi.org/10.1002/ppul.25597
Ota C, Saito R, Tominaga J, Iwasawa S, Hirama T, Matsuda Y, Ono K, Onoki T, Kimura M, Kawabata Y, Okada Y. Bilateral lung transplantation in a 9-year-old girl with bronchopulmonary dysplasia with pulmonary hypertension. Pediatr Pulmonol. 2021 Oct;56(10):3417-3421. doi: 10.1002/ppul.25597. Epub 2021 Aug 05. PMID: 34350735.
Copy Download .nbib Format: NLM
Very-Low-Dose Levodopa Therapy for Pediatric Neurological Disorders: A Preliminary Questionnaire in Japan.

Frontiers in pediatrics

Hoshino K, Hayashi M, Ishizaki A, Kimura K, Kubota M, Nezu A, Yasuhara A.
PMID: 33748036
Front Pediatr. 2021 Mar 04;9:569594. doi: 10.3389/fped.2021.569594. eCollection 2021.

No abstract available.

Cite
Hoshino K, Hayashi M, Ishizaki A, et al. Very-Low-Dose Levodopa Therapy for Pediatric Neurological Disorders: A Preliminary Questionnaire in Japan. Front Pediatr. 2021;9:569594doi: 10.3389/fped.2021.569594.
Hoshino, K., Hayashi, M., Ishizaki, A., Kimura, K., Kubota, M., Nezu, A., & Yasuhara, A. (2021). Very-Low-Dose Levodopa Therapy for Pediatric Neurological Disorders: A Preliminary Questionnaire in Japan. Frontiers in pediatrics, 9569594. https://doi.org/10.3389/fped.2021.569594
Hoshino, Kyoko, et al. "Very-Low-Dose Levodopa Therapy for Pediatric Neurological Disorders: A Preliminary Questionnaire in Japan." Frontiers in pediatrics vol. 9 (2021): 569594. doi: https://doi.org/10.3389/fped.2021.569594
Hoshino K, Hayashi M, Ishizaki A, Kimura K, Kubota M, Nezu A, Yasuhara A. Very-Low-Dose Levodopa Therapy for Pediatric Neurological Disorders: A Preliminary Questionnaire in Japan. Front Pediatr. 2021 Mar 04;9:569594. doi: 10.3389/fped.2021.569594. eCollection 2021. PMID: 33748036; PMCID: PMC7970027.
Copy Download .nbib Format: NLM
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation.

Nature

Saito A, Irie T, Suzuki R, Maemura T, Nasser H, Uriu K, Kosugi Y, Shirakawa K, Sadamasu K, Kimura I, Ito J, Wu J, Iwatsuki-Horimoto K, Ito M, Yamayoshi S, Loeber S, Tsuda M, Wang L, Ozono S, Butlertanaka EP, Tanaka YL, Shimizu R, Shimizu K, Yoshimatsu K, Kawabata R, Sakaguchi T, Tokunaga K, Yoshida I, Asakura H, Nagashima M, Kazuma Y, Nomura R, Horisawa Y, Yoshimura K, Takaori-Kondo A, Imai M, Tanaka S, Nakagawa S, Ikeda T, Fukuhara T, Kawaoka Y, Sato K.
PMID: 34823256
Nature. 2021 Nov 25; doi: 10.1038/s41586-021-04266-9. Epub 2021 Nov 25.

During the current coronavirus disease 2019 (COVID-19) pandemic, a variety of mutations have accumulated in the viral genome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and, at the time of writing, four variants of concern are considered to...

Cite
Saito A, Irie T, Suzuki R, et al. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature. 2021;doi: 10.1038/s41586-021-04266-9.
Saito, A., Irie, T., Suzuki, R., Maemura, T., Nasser, H., Uriu, K., Kosugi, Y., Shirakawa, K., Sadamasu, K., Kimura, I., Ito, J., Wu, J., Iwatsuki-Horimoto, K., Ito, M., Yamayoshi, S., Loeber, S., Tsuda, M., Wang, L., Ozono, S., Butlertanaka, E. P., Tanaka, Y. L., Shimizu, R., Shimizu, K., Yoshimatsu, K., Kawabata, R., Sakaguchi, T., Tokunaga, K., Yoshida, I., Asakura, H., Nagashima, M., Kazuma, Y., Nomura, R., Horisawa, Y., Yoshimura, K., Takaori-Kondo, A., Imai, M., Tanaka, S., Nakagawa, S., Ikeda, T., Fukuhara, T., Kawaoka, Y., & Sato, K. (2021). Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature, . https://doi.org/10.1038/s41586-021-04266-9
Saito, Akatsuki, et al. "Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation." Nature vol. (2021). doi: https://doi.org/10.1038/s41586-021-04266-9
Saito A, Irie T, Suzuki R, Maemura T, Nasser H, Uriu K, Kosugi Y, Shirakawa K, Sadamasu K, Kimura I, Ito J, Wu J, Iwatsuki-Horimoto K, Ito M, Yamayoshi S, Loeber S, Tsuda M, Wang L, Ozono S, Butlertanaka EP, Tanaka YL, Shimizu R, Shimizu K, Yoshimatsu K, Kawabata R, Sakaguchi T, Tokunaga K, Yoshida I, Asakura H, Nagashima M, Kazuma Y, Nomura R, Horisawa Y, Yoshimura K, Takaori-Kondo A, Imai M, Tanaka S, Nakagawa S, Ikeda T, Fukuhara T, Kawaoka Y, Sato K. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature. 2021 Nov 25; doi: 10.1038/s41586-021-04266-9. Epub 2021 Nov 25. PMID: 34823256.
Copy Download .nbib Format: NLM
Idiopathic eosinophilic pleurisy: A practical diagnostic approach.

Respiratory medicine case reports

Haraguchi T, Tashiro H, Takahashi K, Kurihara Y, Sadamatsu H, Miyahara N, Hiratsuka M, Kimura S, Sueoka-Aragane N.
PMID: 34401274
Respir Med Case Rep. 2021 May 20;33:101430. doi: 10.1016/j.rmcr.2021.101430. eCollection 2021.

A 37-year-old man with fever, cough, and dyspnea with no medical history developed an eosinophilic pleural effusion and blood eosinophilia. No evidence of malignancy or pathogens was detected in the pleural effusion, and the pleural specimen obtained by thoracoscopy...

Cite
Haraguchi T, Tashiro H, Takahashi K, et al. Idiopathic eosinophilic pleurisy: A practical diagnostic approach. Respir Med Case Rep. 2021;33:101430doi: 10.1016/j.rmcr.2021.101430.
Haraguchi, T., Tashiro, H., Takahashi, K., Kurihara, Y., Sadamatsu, H., Miyahara, N., Hiratsuka, M., Kimura, S., & Sueoka-Aragane, N. (2021). Idiopathic eosinophilic pleurisy: A practical diagnostic approach. Respiratory medicine case reports, 33101430. https://doi.org/10.1016/j.rmcr.2021.101430
Haraguchi, Tetsuro, et al. "Idiopathic eosinophilic pleurisy: A practical diagnostic approach." Respiratory medicine case reports vol. 33 (2021): 101430. doi: https://doi.org/10.1016/j.rmcr.2021.101430
Haraguchi T, Tashiro H, Takahashi K, Kurihara Y, Sadamatsu H, Miyahara N, Hiratsuka M, Kimura S, Sueoka-Aragane N. Idiopathic eosinophilic pleurisy: A practical diagnostic approach. Respir Med Case Rep. 2021 May 20;33:101430. doi: 10.1016/j.rmcr.2021.101430. eCollection 2021. PMID: 34401274; PMCID: PMC8348509.
Copy Download .nbib Format: NLM
Photodynamic therapy for pulmonary mucoepidermoid carcinoma.

Respiratory medicine case reports

Kimura M, Miyajima K, Ishikawa R, Yamada Y, Kono T, Okunaka T, Iwaya K, Ikeda N.
PMID: 34401275
Respir Med Case Rep. 2021 May 15;33:101431. doi: 10.1016/j.rmcr.2021.101431. eCollection 2021.

Pulmonary mucoepidermoid carcinoma (PMEC) are rare, accounting for 0.1-0.2% of all malignant lung tumors. Furthermore, endobronchial lesions are rare and are more commonly found in the segmental or lobar bronchi. We present, to the best of our knowledge, the...

Cite
Kimura M, Miyajima K, Ishikawa R, et al. Photodynamic therapy for pulmonary mucoepidermoid carcinoma. Respir Med Case Rep. 2021;33:101431doi: 10.1016/j.rmcr.2021.101431.
Kimura, M., Miyajima, K., Ishikawa, R., Yamada, Y., Kono, T., Okunaka, T., Iwaya, K., & Ikeda, N. (2021). Photodynamic therapy for pulmonary mucoepidermoid carcinoma. Respiratory medicine case reports, 33101431. https://doi.org/10.1016/j.rmcr.2021.101431
Kimura, Masakazu, et al. "Photodynamic therapy for pulmonary mucoepidermoid carcinoma." Respiratory medicine case reports vol. 33 (2021): 101431. doi: https://doi.org/10.1016/j.rmcr.2021.101431
Kimura M, Miyajima K, Ishikawa R, Yamada Y, Kono T, Okunaka T, Iwaya K, Ikeda N. Photodynamic therapy for pulmonary mucoepidermoid carcinoma. Respir Med Case Rep. 2021 May 15;33:101431. doi: 10.1016/j.rmcr.2021.101431. eCollection 2021. PMID: 34401275; PMCID: PMC8348553.
Copy Download .nbib Format: NLM
Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis.

Journal of the American Heart Association

Uchiyama S, Toyoda K, Omae K, Saita R, Kimura K, Hoshino H, Sakai N, Okada Y, Tanaka K, Origasa H, Naritomi H, Houkin K, Yamaguchi K, Isobe M, Minematsu K, Matsumoto M, Tominaga T, Tomimoto H, Terayama Y, Yasuda S, Yamaguchi T.
PMID: 34622679
J Am Heart Assoc. 2021 Oct 19;10(20):e022575. doi: 10.1161/JAHA.121.022575. Epub 2021 Oct 08.

Background Long-term benefit of dual antiplatelet therapy (DAPT) over single antiplatelet therapy (SAPT) for the prevention of recurrent stroke has not been established in patients with intracranial arterial stenosis. We compared the efficacy and safety of DAPT with cilostazol...

Cite
Uchiyama S, Toyoda K, Omae K, et al. Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis. J Am Heart Assoc. 2021;10(20):e022575doi: 10.1161/JAHA.121.022575.
Uchiyama, S., Toyoda, K., Omae, K., Saita, R., Kimura, K., Hoshino, H., Sakai, N., Okada, Y., Tanaka, K., Origasa, H., Naritomi, H., Houkin, K., Yamaguchi, K., Isobe, M., Minematsu, K., Matsumoto, M., Tominaga, T., Tomimoto, H., Terayama, Y., Yasuda, S., & Yamaguchi, T. (2021). Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis. Journal of the American Heart Association, 10(20), e022575. https://doi.org/10.1161/JAHA.121.022575
Uchiyama, Shinichiro, et al. "Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis." Journal of the American Heart Association vol. 10,20 (2021): e022575. doi: https://doi.org/10.1161/JAHA.121.022575
Uchiyama S, Toyoda K, Omae K, Saita R, Kimura K, Hoshino H, Sakai N, Okada Y, Tanaka K, Origasa H, Naritomi H, Houkin K, Yamaguchi K, Isobe M, Minematsu K, Matsumoto M, Tominaga T, Tomimoto H, Terayama Y, Yasuda S, Yamaguchi T. Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis. J Am Heart Assoc. 2021 Oct 19;10(20):e022575. doi: 10.1161/JAHA.121.022575. Epub 2021 Oct 08. PMID: 34622679; PMCID: PMC8751870.
Copy Download .nbib Format: NLM
Showing 6085 to 6093 of 6093 entries